85
Cardiac Case Study Haley Fortier, Erika Flynn, Sarah Mayers, Jessica Costa

Full Cardiac Case Study Final

Embed Size (px)

DESCRIPTION

Senior level nursing class. Case study involves a patient receiving tpa and other meds such as MONA

Citation preview

Page 1: Full Cardiac Case Study Final

Cardiac Case StudyHaley Fortier, Erika Flynn, Sarah Mayers,

Jessica Costa

Page 2: Full Cardiac Case Study Final

Chief complaint

• Patient: C.P.

• 52-year-old

• Male

• Experiencing chest pain • Radiating to his left arm and jaw

• Uninsured

Page 3: Full Cardiac Case Study Final

background

• Full-time construction worker

• Four children

• Past episodes of “chest tightness” with exertion • the past six months• first visit to the ED

• Smoked one pack of cigarettes daily for more than 35 years

• Drinks 3-4 beers a day after work.

Page 4: Full Cardiac Case Study Final

Past Medical History

• Atrial Fibrillation

• Elevated CHO

• GERD

• NIDDM

• NKDA

• Surgical history:• total cholecystectomy 10 years ago

Page 5: Full Cardiac Case Study Final

Emergency department

• 12 lead ECG • hyper acute ST elevation • anterior, lateral and inferior leads

• C.P. is continuing to experience substernal “chest pressure” • becoming more anxious

Page 6: Full Cardiac Case Study Final

Lab work on AdmissionNormal Lab Values

Na 135 mmol/L

Co2 28

BUN 12 mg/dL

Ca 10.1

CPK 12.4 ng/ml

ABG PaO2 86PaCO2 35Bicarb 24

Abnormal Lab Values

K 3.0 mmol/L

Cl 101 mEq/L

Glucose 165

Creatinine 2.8 mg/dL

HCO3 18 mmol/L

WBC 14.5

Hgb 8.5 g/dL

Hct 35.3%

INR 3.9

Hgb A1C 7.0

pH 7.30

Do you recognize any lab values that would be of importance in this patients situation?

Page 7: Full Cardiac Case Study Final

What is the priority action?

Page 8: Full Cardiac Case Study Final

Priority action

• Put on cardiac monitor immediately

• Support ABC’s

• Notify the MD

• Have the code cart ready

• Be prepared for CPR and/ or defibrillation

• Know that rapid reperfusion is the priority when a client is experiencing a STEMI we would start to prep the client for the cath lab.

Page 9: Full Cardiac Case Study Final

additional actions

• Put on 2L O₂

• Give 325 mg aspirin

• Insert 2 large bore IV’s (20 or better)

• Give Nitro• Systolic should be greater than 100 before

administering Nitro

• Evaluate VS Q 15 min

• Portable chest X-Ray within 30 minutes

Page 10: Full Cardiac Case Study Final

Immediate concerns

• Reperfusion

• Maintaining BP (ABC’s)

Page 11: Full Cardiac Case Study Final

additional lab values

• Need to obtain:• Troponin • Magnesium

Page 12: Full Cardiac Case Study Final

update

• During interview C.P. reports:• Worsening chest discomfort

• The cardiac monitor shows ST segment elevation

• Physician orders the following: • Administer morphine sulfate 2 mg IV push • Obtain an ECG,• Draw blood for coagulation studies• Administer ranitidine (Zantac) 75 mg orally

every 12 hours.

Page 13: Full Cardiac Case Study Final

Which of these orders will take priority at this time?

Page 14: Full Cardiac Case Study Final

1. Administer morphine sulfate 2 mg IV push2. Obtain an ECG3. Draw blood for coagulation studies4. Administer ranitidine (Zantac) 75 mg orally every 12 hours

Page 15: Full Cardiac Case Study Final

Morphine sulfate

• Nursing considerations: • Solution is colorless; do not administer

discolored solution.• Dilute with at least 5 mL of sterile water

0.9% NaCl for injection

• Concentration: 0.5-5 mg/mL

• Rate: Administer over 5 min. Rapid administration may lead to increased respiratory depression, hypotension, and circulatory collapse.

Page 16: Full Cardiac Case Study Final

Nursing interventions

Morphine Sulfate

• Assess type, location, and intensity of pain prior to and 20 min after IV

• High Alert!! Assess level of consciousness, BP, pulse, and respirations before and periodically during administration. If RR is <10/min, assess level of sedation. Physical stimulation may be sufficient to prevent significant hypoventilation.

• Advise patient to change position slowly to minimize orthostatic hypotension.

Page 17: Full Cardiac Case Study Final

update

• C.P.’s lab work that was sent from your ED and you notice that the laboratory value Troponin T level of more than 0.20 ng/mL was documented.

• What is the significance of this finding?

Page 18: Full Cardiac Case Study Final

Troponin interpretation

• Elevated serum enzyme levels are the result of the necrosis from the MI

• Troponin T > or = to 0.01 are at increased risk for cardiac events.

• His was at .20• Puts him at greater risk for cardiac events.

Page 19: Full Cardiac Case Study Final

Admitting diagnosis

• Positive anterior lateral MI with inferior involvement

Page 20: Full Cardiac Case Study Final

st elevations on ECG

• ST elevation in lead 2, 3, AVF, AVL, and lead 1 in AVL.

Page 21: Full Cardiac Case Study Final

Ecg description to patient

• ST elevation indicates lack of oxygen to the muscle tissue of your heart.

Page 22: Full Cardiac Case Study Final

Myocardium areas

• Anterior lead= left anterior descending coronary artery (LAD)

• Lateral lead= right coronary artery

• Inferior lead= circumflex artery

Page 23: Full Cardiac Case Study Final

Administer TPA?

• NO!

• C.P. INR value= 3.9 seconds (too high)

• Puts patient at risk for bleeding

• Administration contraindicated INR>1.7 seconds

Page 24: Full Cardiac Case Study Final

TPA indications

•ST elevations

•Timeframe

Page 25: Full Cardiac Case Study Final

Tpa contraindications

Absolute

• Hemorrhagic stroke

• Ischemic stroke within 6 mos.

• Recent trauma to the head

• Aortic dissection

• Major GI bleed

• Known bleeding disorder

Relative

• Hypertension systolic >180

• Oral anticoagulation therapy

• Traumatic resuscitation

• Non compressible puncture sites

• Active peptic ulcer

Page 26: Full Cardiac Case Study Final

Dosage

• Total 100mg IV

• 60 mg over 1st hr

• 20 mg over the 2nd hr

• 20 mg over the 3rd

• Usually accompanied by heparin therapy

Page 27: Full Cardiac Case Study Final

Nursing interventions

• Monitor VS including temperature• Continuous or Q4 hours

• Do not use lower extremities to monitor BP• Notify HCP:

• systolic >180 mmHg or diastolic >110mmHg

• Hypotension occurs • Result from drug, hemorrhage, or cardiogenic

shock

Page 28: Full Cardiac Case Study Final

• Assess patient carefully for bleeding • Q 15 min 1st hour of therapy• Q 15-30 min next 8 hours • Q 4 hrs for remaining duration

Page 29: Full Cardiac Case Study Final

• Assess patient for hypersensitivity reaction• Rash• Dyspnea• Fever• Changes in facial color• Swelling around the eyes • Wheezing

• Inform HCP promptly

• Epinephrine, an antihistamine and resuscitation• Anaphylactic reaction

Page 30: Full Cardiac Case Study Final

• Assess neurological status • Intracranial bleeding

• Altered sensorium • Neurological changes

Page 31: Full Cardiac Case Study Final

Risks

• Hypersensitivity reaction

• Frank bleeding may occur • Invasive procedure sites• Body orifices

• Internal bleeding • Decreased neurological status • Abdominal pain

• Coffee-ground emesis or black tarry stools

• Hematuria • Joint pain

• Stroke

Page 32: Full Cardiac Case Study Final

Concerns

• Long term:• Extending the MI • Chance of the patient coding

• Short term:• Contraindicated with anticoagulants • When did the symptoms onset

Page 33: Full Cardiac Case Study Final

Clinical symptoms

• TPA • Epistaxis• Bronchospasm • Hemoptysis • Reperfusion arrhythmias • Hypotension• N/V• Flushing• Phlebitis at injection site• Fever

Page 34: Full Cardiac Case Study Final

UPDATE

• C.P taken to cardiac catheterization lab for further evaluation and intervention. • Part of tx intractable chest pain

Page 35: Full Cardiac Case Study Final

Pre-procedure responsibilities

• Prior to cardiac catheterization lab• Informed consent • Reinforce teaching • Shave/prep the groin• Establish two peripheral venous access sites.• Specimens for lab tests • Chest x-ray • EKG/ECG, baseline vascular observations

Page 36: Full Cardiac Case Study Final

• Additional info obtained • Allergies (contrast agent)• Hx of asthma (increased reaction)

• Withhold or decrease medications• Insulin, antihypertensive, diuretics

• Assess/mark pulses on the extremity • What arteries are used

• what the test consists of

Page 37: Full Cardiac Case Study Final

Pre-op responsibility

• Monitor • PTT• INR• CBC with differential

Page 38: Full Cardiac Case Study Final

What does PTCA stand for?

Page 39: Full Cardiac Case Study Final

What occurs during a ptca?

Page 41: Full Cardiac Case Study Final

Nurse’s explanation

• Patient:• Panicked• Urgent situation

• Nurse:• Advocate for the patient • Calm, soothing, reassuring • Patient’s experience • Patient’s concerns

Page 42: Full Cardiac Case Study Final

UPDate

• C.P• Pain free • Brief V.fib

• Defibrillated two times

• Currently NSR • PTCA

• 3 non medicated stents

• Cardiac cath- right femoral artery

Page 43: Full Cardiac Case Study Final

Update cont.

• Strong pulses bilaterally

• AAOx3

• O2 sat 96% RA

Page 44: Full Cardiac Case Study Final

Return to telemetry unit update

• IV fluids • 0.9% NS at 75 mL/hr• Heparin 25000U/500mL D5W at 1000U/hr• Patent and running

• Vital signs stable • BP 90/58• HR 60• RR 18• Pulse ox 92%

Page 45: Full Cardiac Case Study Final

Additional assessment

• Neurological status

• Signs of bleeding• Frank/internal

• Femoral/ pedal pulses

• Capillary refill

• Feelings and current state of mind

Page 46: Full Cardiac Case Study Final

Additional assessment cont.

• Inspect insertion site • Color, warmth, sensation, movement • Distal pulse • Place mark on sites

• Vascular observations • Q 15min first 2 hours • Hourly remaining 6 hours

Page 47: Full Cardiac Case Study Final

Post-Op complications

• Chest pain• Ischemic chest pain similar to prior pain • Pericarditic chest pain

• Inflammation of pericardium

• Mainstay treatment • Analgesia- NSAIDs

Page 48: Full Cardiac Case Study Final

Possible Post-Op complications

• Renal impairment • Contrast induced nephropathy

• Particularly pre-existing renal failure, diabetic neuropathy and older patients

• Minimize contrast load • Adequate hydration • Stop metformin, NSAIDs before procedure • Oral intake fluids

Page 49: Full Cardiac Case Study Final

Post-op complications

• Bleeding • Aggressive anti-platelet and anti-thrombotic

therapies

• Contact HCP:• Swelling• Blood loss• Tenderness around access site

Page 50: Full Cardiac Case Study Final

Post-op complications

• Pseudoaneurism• Considered in any patient with a hematoma

• Artery fails to close• Pulsatile swelling • Pain on palpitation • Analgesia and atropine

Page 51: Full Cardiac Case Study Final

Post cath ECG

• Goal: baseline rhythm (NSR)

• Resolution of ST elevation

Page 52: Full Cardiac Case Study Final

update

• Unequal pulses in LE

• Weak pedal pulses right side

• Large hematoma right groin

Page 53: Full Cardiac Case Study Final

Nursing action to follow

• 2L O2

• Notify HCP • Fluids • Dopamine

Page 54: Full Cardiac Case Study Final

Post PTCA

• Nursing interventions: • Bed-rest 4-6 hours

• Prevent bleeding at insertion site

• Asses • Vital signs • Delayed allergic reactions

• Rash, tachycardia, hypertension, palpitations, N/V

• Extremities• signs of ischemia, no distal pulse

• Insertion site • Bleeding, inflammation, hematoma

Page 55: Full Cardiac Case Study Final

Post PTCA

• Nursing interventions:• Education

• Resume usual diet, fluids, medications, activity • Observe insertion site • Cold compresses to puncture site • Bed rest 4-6 hours afterwards

• Report to provider • Pleuritic pain, persistent right shoulder pain,

abdominal pain

Page 56: Full Cardiac Case Study Final

Post PTCA

• Positioning• Legs in abduction/ parallel • Lay flat – HOB no higher 30°• Affected extremity kept straight

• 4-6 hours

• Compression applied to avoid bleeding complications

Page 57: Full Cardiac Case Study Final

What labs should continue to be monitored since the patient is receiving

Heparin post PTCA procedure?

Page 58: Full Cardiac Case Study Final

Additional labs

• Monitor PTT

• Monitor platelet count Potassium (may cause hyperkalemia)

• AST and ALT levels (may increase)

Page 59: Full Cardiac Case Study Final

UAP delegation

• Vital signs q15 min(4), every 30min(2), and every 60 min(2): Report Systolic BP under 90

• Check stool to monitor signs of bleeding

• Assist patient with ADL’s and positioning: he must lay flat to prevent bleeding from incision site

• If Nursing Assistant is skilled, have her attach patient to ECG machine

Page 60: Full Cardiac Case Study Final

Which Pharmaceutical treatments would you

give C.p. ? Nitroglycerin

LidocaineDopamineMetroprolol

AspirinAnd heparin

Page 61: Full Cardiac Case Study Final

Medications to administer

• Dopamine: vasopressor/adrenergic, increases cardiac output, increases BP, • contraindicated in: tachyarrhytmias, pheochromocytoma, and

hypersensitivity • Use cautiously in: hypovolemia, myocardial infarction, occlusive

vascular diseases

• Lidocaine: antiarrhythmic, control of ventricular arrhythmias• Contraindicated in: hypersensitivity, third degree heart block• Use cautiously in: HF, respiratory depression, shock, and heart block

• Heparin: antithrombotic, prevention of thrombus formation, prevention of extension of existing thrombi• Contraindicated in: hypersensitivity, uncontrolled bleeding• Use cautiously in: untreated hypertension, history of bleeding

disorder, history of thrombocytopenia

Page 62: Full Cardiac Case Study Final

Concerning labs if not corrected

* Troponin

*Glucose: 80-110 is the goal

*Electrolytes: specifically Magnesium and Potassium

- Potassium 3.0mmol/ml: LOW• Hgb 8.5g/dl and Hct of 35.3%: LOW• Creatinine of 2.8mg/dl: HIGH• INR

Page 63: Full Cardiac Case Study Final

Interdisciplinary care

• Potassium supplementation

• Echocardiogram post cath

• Dietary

• Diabetes education

• Weight loss/ nutrition counseling

• Occupational Therapy

• Smoking cessation- alcohol awareness r/t CAD

• Case worker: health insurance

Page 64: Full Cardiac Case Study Final

CAD risk factors

• Cholesterol: LDL, HDL

• Glucose

• Hgb & Hct: Not enough O₂ in the blood

• Increased BUN and Creatinine- indicates renal impairment

• Hx of high cholesterol, diabetes, smoking, hypertension

• Increased age and weight also has an effect on CAD

Page 65: Full Cardiac Case Study Final

Update

• During his PTCA procedure, a circumflex coronary artery lesion was found

• The PTCA failed in that artery and a stent was inserted

• He remains on lidocaine and dopamine drips

• VS are now stable and PCWP is 20mmHg, and CO is 7.3L/min

Page 66: Full Cardiac Case Study Final

Lidocaine

• Lab results for Patients licocaine level is 2.5 m/ml

• Lidocaine therapeutic levels are between 1.5-5.0 mcq/ml

• Toxicity:• Confusion, excitation, blurred vision,

nausea/vomiting, tinnitus, tremors, twitching, seizures, dyspnea, dizziness, fainting, decreases heart rate

• If occurs, stop infusion, notify the provider and monitor the patient

Page 67: Full Cardiac Case Study Final

Update

• C.P. is becoming increasingly anxious

• Stent was successful and he is stable and present at the time

While continuing to monitor…

- C.P. suddenly becomes faint, immediately loses consciousness and becomes pulseless and apneic

- No BP, and heart sounds are absent

Page 68: Full Cardiac Case Study Final

What will be your first action?

Page 69: Full Cardiac Case Study Final

• Initiate CPR and call code blue!!!!

Page 70: Full Cardiac Case Study Final

Additional steps

• Nurses need to communicate to one another and determine who is leading the code, obtaining emergency code medications and administering

• Be prepared to switch roles for CPR

• Have the code cart available

• Be prepared to give code meds

• Be prepared for intubation

• Room needs to be free of clutter, and patient needs to be easily accessible

Page 71: Full Cardiac Case Study Final

Why initiate CPR?

• C.P. is unresponsive, pulselessness, and apneic

• C.P. has no blood pressure and absent heart sounds

Page 72: Full Cardiac Case Study Final

Update

• The patient is in full cardiac arrest and CPR is in progress.

• The ECG monitor shows PEA.

• What is the priority nursing intervention for this patient?

Page 73: Full Cardiac Case Study Final

• Continue CPR for 2 minutes

• IV/IO access• Administer Epinephrine every 3-5 minutes• Consider advanced airway

• Place electrodes on the client in case a shockable rhythm develops.

Page 74: Full Cardiac Case Study Final

• To the right of the sternum just below the clavicle

• To the left of the anterior axillary line, 5th-6th ICS

Page 75: Full Cardiac Case Study Final

Treat Reversible Causes

• Hypovolemia

• Hypoxia

• Hydrogen ion (acidosis)

• Hypo/hyperkalemia

• Hypothermia

• 5 H’s • 5 T’s

• Tension pneumothorax

• Tamponade, cardiac

• Toxins

• Thrombosis, pulmonary

• Thrombosis, coronary

Page 76: Full Cardiac Case Study Final

Update

• The family is asking to be present in the room during CPR.

• Should this request be honored?

Page 77: Full Cardiac Case Study Final

Role of the Nurse

• Help with resuscitation

• Provide the family with comfort and support

• Keep the family informed

Page 78: Full Cardiac Case Study Final

Will we be performing defibrillation on this

patient?

Page 79: Full Cardiac Case Study Final

Defibrillator Charge

Biphasic

• Initial dose of 120-200 J

• Second and subsequent doses should be equivalent or higher .

Monophasic

• 360 J

Page 80: Full Cardiac Case Study Final

What drugs should the nurse prepare to

administer during the resuscitation?

Page 81: Full Cardiac Case Study Final

Epinephrine (Adrenalin)

• Indication: Part of ACLS guidelines for the management of cardiac arrest

• Action:• Affects both beta₁

(cardiac)-adrenergic receptors and beta₂ (pulmonary)-adrenergic receptor sites

• Alpha-adrenergic agonist properties, which result in vasoconstriction

• Produces bronchodilation

Vasopressin (Pitressin)

• Indication: Management of PEA

• Action:• Alters the

permeability of the renal collection ducts, allowing reabsorption of water

• Directly stimulates musculature of the GI tract

• In high doses acts as a nonadrenergic peripheral vasoconstrictor

Page 82: Full Cardiac Case Study Final

Route, Administration & Dosage

Epinephrine (Adrenalin)

• IV push

• 1 mg q 3-5 minutes

Vasopressin (Pitressin)

• IV push

• 40 units as a single dose

• Can replace first or second dose of epinephrine

Page 83: Full Cardiac Case Study Final

family support

• Offer comfort and support.

• Would you like us to notify your priest or spiritual advisor?

• Is there anything I can get for you (hospitality cart)?

• Is there anything you need to have clarified?

• Ensure social work has been contacted if they are not already there.

• Ensure the family that everything possible is being done to save their loved one.

Page 84: Full Cardiac Case Study Final

Update

The CODE BLUE was ended after 30 minutes of ACLS interventions.

The team was unable to restore C.P.’s pulse

Page 85: Full Cardiac Case Study Final

nurse's responsibility

• Clear all medical equipment and supplies out of the room, cover the patient from the neck down, and make the environment comfortable for the family to mourn

• Listen, answer questions, and provide support for the family

• Ensure they understand everything that was done to try and save their loved one

• Provide referrals

• Post mortem care